Ordena

Cercar

01/04/2025 CNS manifestations in acute and chronic graft-versus-host disease
Lambert, N, Forte, F, El Moussaoui, M, Monseur, J, Raus, N, Polushin, A, Michonneau, D, Shultz, C, Hogan, WJ, Balaguer-Roselló, A, Gil-Perotín, S, Brijs, J, Chauvet, P, Gavriilaki, M, Carre, M, Dulamea, AO, Chalandon, Y, Salmenniemi, U, Duminuco, A, Ram, R, García-Cadenas, I, Porto, G, Nguyen, S, Smallbone, P, González-Vicent, M, Santoro, JD, Willems, E, Baron, F, Servais, S, Beguin, Y, Maquet, P. CNS manifestations in acute and chronic graft-versus-host disease. BRAIN. 2025; 148(4)DOI:10.1093/brain/awae340. PMID:39442000. IF:11.700(Q1/1D).
31/03/2025 Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction
Briones, AM, Hernanz, R, García-Redondo, AB, Rodriguez, C, Blanco-Colio, LM, Val-Blasco, A, Alonso, MJ, Salaices, M. Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2025; 136(5)DOI:10.1111/bcpt.70026. PMID:40159875. IF:3.300(Q2/4D).
30/03/2025 Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis
Afferi, L, Jahn, B, Kelkar, AH, Dijk, SW, Feldman, ZM, Ward, ZJ, Moschini, M, Cathomas, R, Bellmunt, J, Gallioli, A, Breda, A, Fankhauser, CD, Mattei, A, Chang, SL, Siebert, U. Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis. WORLD JOURNAL OF UROLOGY. 2025; 43(1)DOI:10.1007/s00345-025-05584-7. PMID:40159560. IF:2.900(Q2/3D).
29/03/2025 The Spanish GIRO Guideline: A Paradigm Shift in the Management of Obesity in Adults
Lecube, A, Azriel, S, Barreiro, E, Blay, G, Carretero-Gómez, J, Ciudin, A, Fernández, JM, Flores, L, de Hollanda, A, Martínez, E, Miñambres, I, Moizé, V, Morales, C, Ramírez, V, Salvador, J, Soler, MJ, Supervía, M, Valenti, V, Vicente-Rodríguez, G, Vilarrasa, N, Malagón, MM. The Spanish GIRO Guideline: A Paradigm Shift in the Management of Obesity in Adults. Obesity Facts. 2025; 18(4)DOI:10.1159/000544880. PMID:40159422. IF:4.700(Q1/2D).